在患有pT1结直肠癌的患者中,淋巴结转移的分支
Liming Wang1,2, Pengchen Long1,3, Yinggang Chen1
1Department of Gastrointestinal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China.
淋巴结转移 (LNM) 在手术后对pT1N1期结直肠癌 (CRC) 患者的长期存活没有影响. 这表明pT1N1 CRC可能是从IIIA阶段下降的候选人.
科学领域:
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
- 手术病理学手术病理学
背景情况:
- 日本的IIIA期结肠直肠癌 (CRC) 的预后比II期CRC更好.
- 调查pT1CRC中淋巴结转移 (LNM) 的影响至关重要.
- 探索pT1N1CRC降级的可能性是合理的.
研究的目的:
- 确定pT1结直肠癌 (CRC) 患者淋巴结转移 (LNM) 的预后影响.
- 根据LNM状态来评估pT1N1 CRC下降阶段的可能性.
主要方法:
- 在日本对723名彻底切除的PT1CRC患者进行了回顾性队列研究.
- 根据淋巴结转移的存在 (LNM+) 或不存在 (LNM-) 进行分组的患者.
- 在倾向性得分匹配之前和之后的无复发存活率 (RFS) 和癌症特异性存活率 (CSS) 的比较.
主要成果:
- 在13.3%的患者中存在LNM,主要是N1.1.
- 在匹配之前,LNM+瘤更大,淋巴/血管入侵率更高,手术时间/住院时间更长.
- 在匹配后,在LNM+和LNM-组之间没有观察到RFS或CSS的显著差异;LNM+状态不是一个独立的风险因素.
结论:
- 淋巴结转移 (LNM) 不会影响pT1N1CRC患者的长期存活率.
- 具有低复发因子的pT1N1CRC可能适合从IIIA阶段降级.
更多相关视频
09:28Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis
Published on: May 12, 2019
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
相关概念视频
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
